NCT05110040
Multi-model Image of Immunosuppressive Agents in TAO
A Multi-model Image of Immunosuppressive Agents in Thyroid Associated Ophthalmopathy.
Sun Yat-sen University·ClinicalTrials.gov·drugRecruiting
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Thyroid Associated Ophthalmopathy
- Drug/Device/Intervention
- immunosuppressive agent
- Study type
- Interventional
- Intervention type
- drug
Sponsor & location
- Primary sponsor
- Sun Yat-sen University
- Location
- Guangzhou, China
Timeline & enrollment
- Phase
- N/A
- Start date
- Oct 15, 2021
- End date
- Dec 01, 2025
- Enrollment
- 12 participants
Primary outcome
change of macular sensibility
Summary
This study aims to evaluate the efficacy of immunosuppressive agents treating Thyroid
 Associated Ophthalmopathy by multi-model image.
ICD-10 classifications
ThyroiditisDisorders of thyroid glandThyroiditis, unspecifiedOther disorders of thyroidDisorder of thyroid, unspecified
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05110040
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT05110040 through Pure Global AI's free database. This phase not specified trial is sponsored by Sun Yat-sen University and is currently Recruiting. The study focuses on Thyroid Associated Ophthalmopathy. Target enrollment is 12 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.